UiPath is turning a profit now, but can it continue?

Currently, PATH shares trade at a significant 40% discount to peers based on EV/Sales and EV/EBITDA multiples. The transition ...

DAVE's rapid revenue growth, improving credit metrics and cheaper valuation set it apart in a head-to-head with PATH's AI-driven automation push.

WASHINGTON, D.C. / ACCESS Newswire / September 30, 2025 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers ...